Article Sidebar

PDF (Tiếng Việt)
Published: 2025-05-22
Abstract Views: 21
Views PDF (Tiếng Việt): 4
DOI: https://doi.org/10.52163/yhc.v66iCD7.2415
Issue
Vol. 66 No. CĐ7- HNKH Bệnh viện K
Section
Articles
How to Cite
Ly, L. T. M., Giang, L. T., Lan, N. T. N., Việt, N. V., & Dương, N. Đức. (2025). 32. NUTRITIONAL STATUS IN ORAL CAVITY CANCER PATIENTS RECEIVING CONCURRENT CHEMORADIATION THERAPY. Vietnam Journal of Community Medicine, 66(CĐ7- HNKH Bệnh viện K). https://doi.org/10.52163/yhc.v66iCD7.2415

32. NUTRITIONAL STATUS IN ORAL CAVITY CANCER PATIENTS RECEIVING CONCURRENT CHEMORADIATION THERAPY

Lai Thi Mai Ly1, Le Thi Giang1, Nguyen Thi Ngoc Lan1, Nguyen Van Viet1, Nguyen Duc Duong2
1 Department of Head and Neck Radiation Oncology - Nghe An Cancer Hospital
2 Vinh University of Medicine and Pharmacy

Main Article Content

Abstract

Objective: Description of certain clinical and nutritional characteristics of patients with oral cavity cancer undergoing concurrent chemoradiotherapy at Nghe An Oncology Hospital from January 2024 to September 2024.
Subjects and Methods: This is a descriptive, prospective cohort study involving 40 oral cancer patients receiving chemoradiotherapy. Data was collected through interviews, medical records, and assessment of weight before and after treatment.
Results: The weight loss rate was 57.5%, with an average weight loss of 4 ± 1.5 kg. The weight loss rate was higher in patients aged ≥ 60 years (64%), female patients (62.5%), and especially in those with a BMI ≥ 23 kg/m² before treatment (82.4%). Patients with periodontitis (83.3%), in stages III–IV of the disease (67.7%), and not receiving tube feeding (72.7%) also had a higher rate of weight loss. Treatment toxicity symptoms contributing to increased weight loss included grade III oral mucositis (76.9%), dysphagia (70.8%), xerostomia (69%), nausea/vomiting (76.9%), trismus (80%), fatigue (60%), anorexia (60%), and gastrointestinal disturbances (53.8%).
Conclusion: Weight loss is a common issue in oral cancer patients undergoing chemoradiotherapy, particularly in those overweight before treatment. Regular weight monitoring and early nutritional intervention are essential to mitigate the negative impact of weight loss on treatment outcomes and patients' quality of life.

Article Details

Keywords

Weight loss, oral cancer, chemoradiotherapy, quality of life

References

[1] I. Panarese et al., “Oral and Oropharyngeal squamous cell carcinoma: prognostic and predictive parameters in the etiopathogenetic route,” Expert Rev Anticancer Ther, vol. 19, no. 2, pp. 105–119, Feb. 2019.
[2] F. Bray et al., “Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries,” CA: A Cancer Journal for Clinicians, vol. 74, no. 3, pp. 229–263, 2024.
[3] “Cancer Today.” Accessed: Apr. 08, 2025.
[4] J. M. Price et al., “Pretreatment Lymphocyte Count Predicts Benefit From Concurrent Chemotherapy With Radiotherapy in Oropharyngeal Cancer,” J Clin Oncol, vol. 40, no. 20, pp. 2203–2212, Jul. 2022.
[5] T. Cederholm et al., “GLIM criteria for the diagnosis of malnutrition - A consensus report from the global clinical nutrition community,” Clin Nutr, vol. 38, no. 1, pp. 1–9, Feb. 2019.
[6] S. Ottosson, B. Zackrisson, E. Kjellén, P. Nilsson, and G. Laurell, “Weight loss in patients with head and neck cancer during and after conventional and accelerated radiotherapy,” Acta Oncol, vol. 52, no. 4, pp. 711–718, May 2013.
[7] V. Nazari, A. S. Pashaki, and E. Hasanzadeh, “The reliable predictors of severe weight loss during the radiotherapy of Head and Neck Cancer,” Cancer Treat Res Commun, vol. 26, p. 100281, 2021.
[8] Nguyễn Thị Hải Yến, “Đánh giá tình trạng sút cân trên bệnh nhân điều trị ung thư đầu cổ tại Bệnh viện K,” National Cancer Institute, vol. X1, no. 2, 2021.
[9] B. Vangelov, R. L. Venchiarutti, and R. I. Smee, “Critical Weight Loss in Patients With Oropharynx Cancer During Radiotherapy (± Chemotherapy),” Nutr Cancer, vol. 69, no. 8, pp. 1211–1218, 2017.